← Back to front page
United States · Platforms & data · MarketBeat

Zacks Research Cuts Earnings Estimates for Gilead Sciences

Published by MarketBeat · United States 26 min ago
Image from MarketBeat Media, LLC.
Image from MarketBeat Media, LLC. · MarketBeat

Detailed summary

Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) - Investment analysts at Zacks Research reduced their FY2026 earnings estimates for Gilead Sciences in a research report issued to clients and investors on Thursday, November 12th. Zacks Research analyst Team now expects that the biopharmaceutical co

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading